Moreover, the detection of a characteristic signature of three autoantibodies (anti-IFN-ω + anti-IFN-α-2a + anti-IL-22) in a patient via this microarray allows the identification of patients with APS-1 with 100% specificity. Here, IL22 is linked to autoimmune polyendocrinopathy.